Stem cell mobilization and transplantation represent pivotal advances in the management of multiple myeloma. This therapeutic approach involves stimulating the release of haematopoietic stem cells ...
Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a ...
Prognostic value of absolute monocyte count in diffuse large B-cell lymphoma patient with autologous peripheral blood stem cell transplant. This is an ASCO Meeting Abstract from the 2014 ASCO Annual ...
June 19 is marked as World Sickle Cell Awareness Day, granting the opportunity to reflect on the current state of treatment, access, equity, and more that impacts patients living with sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback